Aesthetic Outcome of Complex Linear Closure vs Second Intention Healing: Below the Knee
Launched by UNIVERSITY OF CALIFORNIA, DAVIS · Sep 29, 2021
Trial Information
Current as of November 05, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study at the University of California, Davis is testing which wound-healing method gives a nicer-looking scar after skin surgery below the knee. It’s a randomized, evaluator-blinded trial, meaning people are assigned by chance to one of two options and careful observers who rate the scars don’t know which method was used. One group will have the wound closed with two layers of sutures (complex linear closure); the other group will have no sutures and the wound will heal on its own (second intention healing). About 172 adults are planned to join.
If you participate, you’d be 18 or older, able to consent, and scheduled for a below-knee skin procedure with a scar of at least 1 cm. You’ll be followed over 3 to 12 months with assessments of scar appearance using a standard scar rating scale (POSAS) and a measurement of scar width, plus checks for any complications (like infection or wound reopening) and a quality-of-life questionnaire. The main goal is to see which method yields a more cosmetic scar, while also noting safety and how the scar affects daily life. The trial is currently enrolling by invitation and is expected to continue through 2030 at UC Davis in Sacramento.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years of age or older
- • Able to give informed consent themselves
- • Patient scheduled for cutaneous surgical procedure below the knee with a lesion excision diameter of at least 1 cm.
- • Willing to return for follow up visit
- Exclusion Criteria:
- • Incarceration
- • Under 18 years of age
- • Pregnant Women
About University Of California, Davis
The University of California, Davis (UC Davis) is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials and studies. With a strong focus on interdisciplinary collaboration, UC Davis leverages its extensive expertise in medical research, education, and patient care to drive breakthroughs in various fields, including medicine, public health, and agriculture. The university's clinical trial programs emphasize rigorous scientific methodology and ethical standards, aiming to translate research findings into impactful treatments and improved patient outcomes. Through its state-of-the-art facilities and a dedicated team of researchers and healthcare professionals, UC Davis is at the forefront of transforming healthcare practices and addressing critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sacramento, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials